EGFR and non-small cell lung carcinoma: Third, there is not enough data to explore the relationship between comutations with EGFR and ICI efficacy in this kind of patient, as our previous study indicated comutation of EGFR and PI3K signaling had interaction effects on ICI treatment in nonsquamous NSCLC (33).